These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10702615)

  • 61. Quantitative structure-activity relationship (QSAR) applications in chemical carcinogenesis. III. QSAR analysis of some phenolic antioxidants.
    Niculescu-Duvåz I; Simon Z; Tiriac S; Ionescu A; Mracec M; Voiculetz N
    Neoplasma; 1985; 32(6):695-707. PubMed ID: 4088389
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and quantitative structure-activity relationships of diclofenac analogues.
    Moser P; Sallmann A; Wiesenberg I
    J Med Chem; 1990 Sep; 33(9):2358-68. PubMed ID: 2118185
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analogue-based design, synthesis and docking of non-steroidal anti-inflammatory agents. Part 2: methyl sulfanyl/methyl sulfonyl substituted 2,3-diaryl-2,3-dihydro-1H-quinazolin-4-ones.
    Manivannan E; Chaturvedi SC
    Bioorg Med Chem; 2012 Dec; 20(24):7119-27. PubMed ID: 23146282
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Singlet oxygen scavenging activity of non-steroidal anti-inflammatory drugs.
    Costa D; Gomes A; Lima JL; Fernandes E
    Redox Rep; 2008; 13(4):153-60. PubMed ID: 18647485
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rational estimation of the QSAR (quantitative structure-activity relationships) descriptors sigmaS0, and their applications for medicinals now available.
    Sasaki Y; Takagi T; Kawaki H
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):415-23. PubMed ID: 8097436
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Application of QSAR Analysis and Different Quantum Chemical Calculation Methods in Activity Evaluation of Selected Fluoroquinolones.
    Kawczak P; Bober L; Bączek T
    Comb Chem High Throughput Screen; 2018; 21(7):468-475. PubMed ID: 30147010
    [TBL] [Abstract][Full Text] [Related]  

  • 67. On the interpretability of quantitative structure-activity relationships (QSAR).
    Franke R
    Farmaco Sci; 1979 Jun; 34(6):545-70. PubMed ID: 467631
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lead optimization on conventional non-steroidal anti-inflammatory drugs: an approach to reduce gastrointestinal toxicity.
    Narsinghani T; Sharma R
    Chem Biol Drug Des; 2014 Jul; 84(1):1-23. PubMed ID: 24460671
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A review on quantitative structure-activity relationships (QSARs) of natural and synthetic antioxidants compounds.
    Kontogiorgis AC; Pontiki AE; Hadjipavlou-Litina D
    Mini Rev Med Chem; 2005 Jun; 5(6):563-74. PubMed ID: 15974934
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative QSAR analysis of cyclo-oxygenase2 inhibiting drugs.
    Mohanapriya A; Achuthan D
    Bioinformation; 2012; 8(8):353-8. PubMed ID: 22570515
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Exploring the influence of steric, electronic and lipophilic descriptors of 1,3-diarly propenones on their anti-inflammatory activity.
    Bhatia NM; Mahadik KR; Bhatia MS
    Daru; 2010; 18(3):230-6. PubMed ID: 22615621
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure-activity prediction networks (SAPNets): a step beyond Nano-QSAR for effective implementation of the safe-by-design concept.
    Rybińska-Fryca A; Mikolajczyk A; Puzyn T
    Nanoscale; 2020 Oct; 12(40):20669-20676. PubMed ID: 33048104
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization process.
    Sushko Y; Novotarskyi S; Körner R; Vogt J; Abdelaziz A; Tetko IV
    J Cheminform; 2014; 6(1):48. PubMed ID: 25544551
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Top Ten NSAIDS. A molecular modelling study.
    Winiwarter S; Roth HJ
    Pharm Acta Helv; 1994 Jan; 68(3):181-9. PubMed ID: 8121927
    [TBL] [Abstract][Full Text] [Related]  

  • 76. QSAR DataBank - an approach for the digital organization and archiving of QSAR model information.
    Ruusmann V; Sild S; Maran U
    J Cheminform; 2014; 6():25. PubMed ID: 24910716
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Qsar Study of Azole Derivatives Using Molecular Descriptors for Quantum Molecular States.
    Amzoiu MO; Cristea OM
    Curr Health Sci J; 2016; 42(2):125-129. PubMed ID: 30568822
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-inflammatory activity of ansamycins.
    Labro MT
    Expert Rev Anti Infect Ther; 2005 Feb; 3(1):91-103. PubMed ID: 15757460
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterizing the Relationship Between the Chemical Structures of Drugs and their Activities on Primary Cultures of Pediatric Solid Tumors.
    Simeon S; Ghislat G; Ballester P
    Curr Med Chem; 2021; 28(38):7830-7839. PubMed ID: 33874867
    [TBL] [Abstract][Full Text] [Related]  

  • 80. QSAR analysis of substituent effects on tambjamine anion transporters.
    Knight NJ; Hernando E; Haynes CJE; Busschaert N; Clarke HJ; Takimoto K; García-Valverde M; Frey JG; Quesada R; Gale PA
    Chem Sci; 2016 Feb; 7(2):1600-1608. PubMed ID: 29899901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.